Cargando...
STINGel: Controlled Release of a Cyclic Dinucleotide for Enhanced Cancer Immunotherapy
Recent advancements in the field of immunotherapy have yielded encouraging results for the treatment of advanced cancers. Cyclic dinucleotides (CDNs) are a powerful new class of immunotherapy drugs known as STING (Stimulator of Interferon Genes) agonists, currently in clinical trials. However, previ...
Gardado en:
| Publicado en: | Biomaterials |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5840037/ https://ncbi.nlm.nih.gov/pubmed/29454236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biomaterials.2018.01.035 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|